Cue Biopharma, Inc.
Cue Biopharma, Inc.（CUE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cue · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$7.00
Consensus
$4.33
-85.1% upside
Low
$2.00
Median: $4 · Last Close: $29.08
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$4.33
-85.1% upside
High Target
$7
-75.9%
Low Target
$2
-93.1%
Current Price
$29.08
as of today
Based on analyst price targets, the CUE stock price prediction for the next 12 months ranges from $2 to $7. The consensus CUE price forecast of $4.33 implies -85.1% upside from the current price of $29.08.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $30.53 | ↑ 5.00% |
1-day model range: $30.08–$30.99. Peak: $30.99 (+5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CUE · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-04-02 | Citizens Capital Markets | Maintains | Market Outperform→Market Outperform |
| 2024-08-20 | Stifel | Maintains | Buy→Buy |
| 2024-07-26 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-07-26 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-04-09 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-04-09 | Stifel | Maintains | Buy→Buy |
| 2024-04-03 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-11-06 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-06-15 | Stifel | Maintains | Buy→Buy |
| 2023-05-15 | JMP Securities | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Cue Biopharma, Inc. (CUE) stock. Of the recent 26 rating actions, 0 were upgrades and 0 were downgrades. 9 analysts currently cover CUE.
分析师推荐趋势
CUE analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$7M
↑ 550.0% YoY
Revenue Next Year
$13M
↑ 96.9% YoY
EPS This Year
$-12.00
EPS Next Year
$-6.64
↓ 44.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast CUE EPS of $-12.00 for the current fiscal year, based on estimates from 1 analysts. The CUE revenue forecast is $7M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CUE 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CUE 的共识目标价为 $4.33（-85.1% 上行空间），分析师共识为 Buy。
CUE 的短期预测（明日）为 $30.53（+5.00%）。
Cue Biopharma, Inc. 在 NASDAQ 上市，代码 CUE。CUE 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CUE 预测 · 8 个问题根据 9 位华尔街分析师，CUE 的 12 个月平均目标价为 $4.33，最高 $7.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $29.08，隐含约 -85.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.